Genetically engineered probiotics as catalytic glucose depriver for tumor starvation therapy
Cancer cells predominantly adapt the frequent but less efficient glycolytic process to produce ATPs c12a microphone rather than the highly efficient oxidative phosphorylation pathway.Such a regulated metabolic pattern in cancer cells offers promising therapeutic opportunities to kill tumors by glucose depletion or glycolysis blockade.In addition, t